Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes, Gestational | 6 | 2025 | 142 | 3.980 |
Why?
|
| Pregnancy Complications, Cardiovascular | 5 | 2026 | 38 | 3.470 |
Why?
|
| Pregnancy | 34 | 2026 | 2370 | 3.150 |
Why?
|
| Hypoglycemic Agents | 5 | 2026 | 225 | 2.650 |
Why?
|
| Pregnancy in Diabetics | 3 | 2026 | 12 | 2.580 |
Why?
|
| Hypertension, Pregnancy-Induced | 6 | 2025 | 50 | 2.450 |
Why?
|
| Pre-Eclampsia | 4 | 2024 | 72 | 2.210 |
Why?
|
| Arrhythmias, Cardiac | 4 | 2026 | 162 | 2.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2026 | 731 | 2.000 |
Why?
|
| Cesarean Section | 4 | 2024 | 100 | 1.720 |
Why?
|
| Retrospective Studies | 22 | 2026 | 6859 | 1.480 |
Why?
|
| Hypoglycemia | 2 | 2023 | 64 | 1.420 |
Why?
|
| Prediabetic State | 2 | 2022 | 54 | 1.390 |
Why?
|
| Infant, Newborn | 12 | 2025 | 1418 | 1.390 |
Why?
|
| Glucose Intolerance | 2 | 2022 | 90 | 1.360 |
Why?
|
| Pregnancy Outcome | 7 | 2026 | 197 | 1.300 |
Why?
|
| Obstetric Labor Complications | 2 | 2021 | 23 | 1.260 |
Why?
|
| Female | 38 | 2026 | 33982 | 1.210 |
Why?
|
| Metformin | 2 | 2026 | 75 | 1.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2023 | 630 | 1.030 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2026 | 14 | 0.950 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2025 | 13 | 0.930 |
Why?
|
| Atrial Flutter | 1 | 2026 | 33 | 0.930 |
Why?
|
| Congenital Abnormalities | 1 | 2025 | 25 | 0.920 |
Why?
|
| Ebstein Anomaly | 1 | 2025 | 5 | 0.920 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2025 | 147 | 0.870 |
Why?
|
| Heart Failure | 4 | 2026 | 953 | 0.860 |
Why?
|
| Labor, Obstetric | 2 | 2023 | 35 | 0.850 |
Why?
|
| Humans | 38 | 2026 | 65168 | 0.850 |
Why?
|
| Heart Diseases | 2 | 2024 | 222 | 0.830 |
Why?
|
| Stillbirth | 1 | 2023 | 18 | 0.810 |
Why?
|
| Labor Presentation | 1 | 2023 | 3 | 0.790 |
Why?
|
| Prenatal Diagnosis | 1 | 2023 | 40 | 0.790 |
Why?
|
| Adult | 21 | 2026 | 17331 | 0.790 |
Why?
|
| Aneuploidy | 1 | 2023 | 42 | 0.790 |
Why?
|
| Dyspnea | 1 | 2024 | 120 | 0.790 |
Why?
|
| Cervical Ripening | 1 | 2023 | 11 | 0.780 |
Why?
|
| Chorioamnionitis | 2 | 2023 | 15 | 0.770 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2023 | 62 | 0.770 |
Why?
|
| Labor, Induced | 1 | 2023 | 26 | 0.760 |
Why?
|
| Genetic Testing | 1 | 2023 | 141 | 0.750 |
Why?
|
| Postpartum Period | 3 | 2023 | 189 | 0.710 |
Why?
|
| Mitral Valve Prolapse | 1 | 2021 | 11 | 0.700 |
Why?
|
| Insulins | 1 | 2021 | 15 | 0.700 |
Why?
|
| Hysterotomy | 1 | 2021 | 1 | 0.680 |
Why?
|
| Uterine Rupture | 1 | 2021 | 6 | 0.680 |
Why?
|
| Vagina | 2 | 2018 | 87 | 0.670 |
Why?
|
| Echocardiography | 1 | 2024 | 508 | 0.650 |
Why?
|
| Blood Glucose | 4 | 2023 | 497 | 0.630 |
Why?
|
| Vaginal Neoplasms | 1 | 2018 | 4 | 0.570 |
Why?
|
| Lacerations | 1 | 2018 | 15 | 0.570 |
Why?
|
| Perineum | 1 | 2018 | 19 | 0.570 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2018 | 16 | 0.570 |
Why?
|
| Menorrhagia | 1 | 2018 | 19 | 0.560 |
Why?
|
| Rejuvenation | 1 | 2018 | 3 | 0.560 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2019 | 70 | 0.550 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2019 | 96 | 0.550 |
Why?
|
| Bacteremia | 1 | 2019 | 91 | 0.540 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2018 | 49 | 0.540 |
Why?
|
| Burkitt Lymphoma | 1 | 2018 | 74 | 0.530 |
Why?
|
| United States | 8 | 2026 | 8209 | 0.520 |
Why?
|
| Atrial Fibrillation | 1 | 2026 | 879 | 0.510 |
Why?
|
| Risk Factors | 7 | 2025 | 5425 | 0.490 |
Why?
|
| Pregnancy in Adolescence | 1 | 2016 | 21 | 0.480 |
Why?
|
| Pregnancy Rate | 1 | 2016 | 31 | 0.480 |
Why?
|
| Contraception Behavior | 1 | 2016 | 37 | 0.470 |
Why?
|
| Insulin | 3 | 2026 | 695 | 0.470 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 860 | 0.460 |
Why?
|
| Logistic Models | 4 | 2024 | 1269 | 0.440 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 800 | 0.440 |
Why?
|
| Antihypertensive Agents | 2 | 2025 | 179 | 0.380 |
Why?
|
| Peripartum Period | 2 | 2024 | 17 | 0.350 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 385 | 0.350 |
Why?
|
| Parturition | 2 | 2021 | 53 | 0.340 |
Why?
|
| Prenatal Care | 2 | 2025 | 169 | 0.330 |
Why?
|
| Counseling | 2 | 2025 | 373 | 0.330 |
Why?
|
| Glucose | 2 | 2023 | 474 | 0.310 |
Why?
|
| Parity | 2 | 2023 | 71 | 0.310 |
Why?
|
| Young Adult | 6 | 2025 | 4811 | 0.290 |
Why?
|
| Contraception | 2 | 2022 | 72 | 0.280 |
Why?
|
| Infant | 2 | 2023 | 1692 | 0.260 |
Why?
|
| Delivery, Obstetric | 2 | 2018 | 59 | 0.250 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2026 | 15 | 0.240 |
Why?
|
| Cushing Syndrome | 1 | 2025 | 10 | 0.230 |
Why?
|
| Renal Artery Obstruction | 1 | 2025 | 18 | 0.230 |
Why?
|
| Aortic Coarctation | 1 | 2025 | 12 | 0.230 |
Why?
|
| Hyperaldosteronism | 1 | 2025 | 9 | 0.230 |
Why?
|
| Thyroid Diseases | 1 | 2025 | 29 | 0.230 |
Why?
|
| Pheochromocytoma | 1 | 2025 | 32 | 0.230 |
Why?
|
| Troponin I | 1 | 2025 | 36 | 0.230 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2025 | 58 | 0.230 |
Why?
|
| Obesity | 2 | 2025 | 1273 | 0.220 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2025 | 52 | 0.220 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2025 | 62 | 0.210 |
Why?
|
| Adolescent | 4 | 2021 | 6296 | 0.210 |
Why?
|
| Pericardial Effusion | 1 | 2024 | 22 | 0.210 |
Why?
|
| Peptide Fragments | 1 | 2025 | 414 | 0.200 |
Why?
|
| Infusions, Intravenous | 1 | 2023 | 174 | 0.190 |
Why?
|
| Heart Defects, Congenital | 1 | 2024 | 101 | 0.190 |
Why?
|
| Heart Valve Diseases | 1 | 2024 | 93 | 0.190 |
Why?
|
| Endometrial Neoplasms | 1 | 2023 | 68 | 0.190 |
Why?
|
| Cohort Studies | 3 | 2024 | 2618 | 0.190 |
Why?
|
| Gestational Age | 1 | 2023 | 192 | 0.180 |
Why?
|
| Carbohydrates | 1 | 2022 | 39 | 0.180 |
Why?
|
| Contraceptive Effectiveness | 1 | 2022 | 3 | 0.180 |
Why?
|
| Acculturation | 1 | 2022 | 38 | 0.180 |
Why?
|
| Cardiomyopathies | 1 | 2024 | 138 | 0.180 |
Why?
|
| Early Diagnosis | 1 | 2021 | 95 | 0.170 |
Why?
|
| Prevalence | 1 | 2025 | 1445 | 0.170 |
Why?
|
| Trial of Labor | 1 | 2021 | 7 | 0.170 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2025 | 804 | 0.170 |
Why?
|
| Preconception Care | 1 | 2021 | 23 | 0.170 |
Why?
|
| Electrocardiography | 1 | 2024 | 553 | 0.170 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 211 | 0.160 |
Why?
|
| Hypertension | 1 | 2025 | 612 | 0.150 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 740 | 0.150 |
Why?
|
| Odds Ratio | 1 | 2021 | 753 | 0.150 |
Why?
|
| Heart Arrest | 1 | 2021 | 175 | 0.150 |
Why?
|
| Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2019 | 4 | 0.150 |
Why?
|
| Uterine Diseases | 1 | 2019 | 9 | 0.150 |
Why?
|
| Extraction, Obstetrical | 1 | 2018 | 1 | 0.140 |
Why?
|
| Puerperal Disorders | 1 | 2019 | 15 | 0.140 |
Why?
|
| Episiotomy | 1 | 2018 | 3 | 0.140 |
Why?
|
| Fever | 1 | 2019 | 65 | 0.140 |
Why?
|
| Diet | 1 | 2022 | 536 | 0.140 |
Why?
|
| Laparoscopy | 1 | 2023 | 490 | 0.140 |
Why?
|
| Narcotics | 1 | 2018 | 57 | 0.140 |
Why?
|
| Pelvis | 1 | 2018 | 62 | 0.140 |
Why?
|
| Surgery, Plastic | 1 | 2018 | 19 | 0.140 |
Why?
|
| Boston | 1 | 2018 | 258 | 0.130 |
Why?
|
| Gravidity | 1 | 2016 | 11 | 0.120 |
Why?
|
| Ultrasonography | 1 | 2018 | 489 | 0.120 |
Why?
|
| Evoked Potentials | 1 | 2016 | 39 | 0.120 |
Why?
|
| Arousal | 1 | 2016 | 42 | 0.120 |
Why?
|
| Pattern Recognition, Visual | 1 | 2016 | 37 | 0.120 |
Why?
|
| Abortion, Induced | 1 | 2016 | 29 | 0.120 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 2703 | 0.120 |
Why?
|
| Prospective Studies | 2 | 2025 | 3310 | 0.120 |
Why?
|
| Exercise | 1 | 2022 | 963 | 0.110 |
Why?
|
| Brain Mapping | 1 | 2016 | 239 | 0.110 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 463 | 0.110 |
Why?
|
| Hospitalization | 1 | 2021 | 1391 | 0.100 |
Why?
|
| Emotions | 1 | 2016 | 233 | 0.100 |
Why?
|
| Inflammation | 1 | 2019 | 1187 | 0.090 |
Why?
|
| Stroke | 1 | 2021 | 1325 | 0.090 |
Why?
|
| Case-Control Studies | 2 | 2025 | 1140 | 0.080 |
Why?
|
| Child | 1 | 2021 | 4606 | 0.080 |
Why?
|
| Abruptio Placentae | 1 | 2024 | 2 | 0.050 |
Why?
|
| Umbilical Arteries | 1 | 2024 | 10 | 0.050 |
Why?
|
| Blood Gas Analysis | 1 | 2024 | 34 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2025 | 170 | 0.050 |
Why?
|
| Fetal Blood | 1 | 2024 | 72 | 0.050 |
Why?
|
| Operative Time | 1 | 2024 | 93 | 0.050 |
Why?
|
| ROC Curve | 1 | 2024 | 292 | 0.050 |
Why?
|
| Observational Studies as Topic | 1 | 2023 | 66 | 0.050 |
Why?
|
| Hysterectomy | 1 | 2023 | 71 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2025 | 526 | 0.050 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2023 | 127 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 373 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2025 | 765 | 0.040 |
Why?
|
| Biomarkers | 1 | 2025 | 1479 | 0.040 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 1 | 2019 | 4 | 0.040 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 407 | 0.040 |
Why?
|
| Decision Trees | 1 | 2019 | 48 | 0.040 |
Why?
|
| Surveys and Questionnaires | 1 | 2025 | 2756 | 0.030 |
Why?
|
| Time Factors | 1 | 2024 | 3873 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 1163 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 2016 | 129 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2016 | 156 | 0.030 |
Why?
|
| Incidence | 1 | 2019 | 1419 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 729 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 1695 | 0.030 |
Why?
|
| Middle Aged | 1 | 2024 | 18252 | 0.020 |
Why?
|
| Male | 1 | 2016 | 31020 | 0.010 |
Why?
|